Investigation and analysis of the current status of pediatric dose division practices in China
- VernacularTitle:我国儿童用药分剂量工作现状调查与分析
- Author:
Jing SHI
1
;
Ruofei TONG
1
;
Qian LIU
1
;
Qian LIU
1
;
Yanyan SUN
2
Author Information
1. Dept. of Pharmacy,Children’s Hospital,Tianjin University/Tianjin Children’s Hospital,Tianjin 300134,China;Tianjin Key Laboratory of Birth Defects for Prevention and Treatment,Tianjin 300134,China
2. Dept. of Pharmacy,Children’s Hospital,Tianjin University/Tianjin Children’s Hospital,Tianjin 300134,China
- Publication Type:Journal Article
- Keywords:
dose division;
Pediatric medication;
status survey;
Refined management
- From:
China Pharmacy
2026;37(21):2784-2788
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To investigate the current status of pediatric dose division in medical institutions in China, and to provide a reference for the standardization of pediatric dose division in China.METHODS Convenience sampling was adopted to conduct stratified sampling of tertiary grade A children’s hospitals, maternal and child health hospitals, and general medical nationwide. Questionnaires were distributed to pharmaceutical professionals responsible for pediatric drug dose division. The questionnaire covered 38 core indicators across 6 dimensions: institutional protocols, drug management, personnel training, equipment usage, environmental management, and risk control. Descriptive analysis of the survey results was performed using Excel 2019 software.RESULTS A total of 43 sample medical institutions were included, with a questionnaire response rate of 100%. Among them, 72.09% of the institutions had established a management system for pediatric drug dose division; 76.74% had established a storage and shelf-life management system for pediatric dose division, but the refined management of these systems urgently needs to be strengthened. 67.44% of medical institutions have established personnel training systems, but only 27.91% conduct training at least once annually. 51.16% of the institutions mainly adopted a hybrid mode combining automatic dose-packaging machines and manual operation, with significantly insufficient investment in automated equipment; 46.51% of the institutions had independent operation spaces and supporting infrastructure for dose splitting; 39.53% had no independent operation space but were equipped with independent operation benches; 81.40% of the institutions had established error prevention and emergency response systems for dose splitting, but the refinement level of these systems was generally insufficient, with room for improvement in operability and emergency guidance capacity.CONCLUSIONS Management systems for pediatric drug dose division in China still have deficiencies in risk control, drug storage and shelf-life management, personnel training and assessment, etc.; the provision of automated equipment and occupational protection facilities remains inadequate. It is recommended to develop standard operating guidelines for pediatric drug dose division, unify management standards, and improve the quality of pediatric pharmaceutical care.